Follow The Filings

ABEO Abeona Therapeutics

Abeona Therapeutics earnings company data as of 8:10 AM ET 11/16

  • 1 of 2 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS -0.17 -0.08 Beat
Rev — $13.5M —
FY2026 Q2 13 Aug EPS -0.25 -0.35 Miss
Rev — $11.4M —

Insider trades

Open-market buys and sales by ABEO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ABEO insider trades
  • $34K bought by 1 insider
  • $259K sold by 2 insiders outside a trading plan
  • $547K sold by 3 insiders under 10b5-1 plans
  1. Faith L. Charles Director
    Buy
    $34K 15,000 shares at $2.29 +8.5% to stake
    Traded Nov 13 Filed Nov 16
  2. Mark Alvino Director
    Sale
    $88K 15,000 shares at $5.86 20% of stake
    Traded Sep 1 Filed Sep 1
  3. Leila Alland Director
    Sale
    $65K 11,000 shares at $5.92 6.3% of stake
    Traded Jun 30 Filed Jul 2
  4. Joseph Walter Vazzano CFO
    Planned sale
    $138K 25,646 shares at $5.39 4.7% of stake
    Traded Jun 9 Filed Jun 9
  5. Mark Alvino Director
    Sale
    $35K 6,500 shares at $5.46 7.7% of stake
    Traded May 22 Filed May 22
  6. Eric Crombez Director
    Planned sale
    $145K 26,143 shares at $5.53 41% of stake
    Traded May 15 Filed May 15
  7. Vishwas Seshadri CEO
    Planned sale
    $131K 29,985 shares at $4.38 2.1% of stake
    Traded Mar 31 Filed Mar 31
  8. Mark Alvino Director
    Sale
    $71K 13,500 shares at $5.23 22% of stake
    Traded Jan 21 Filed Jan 21
  9. Vishwas Seshadri CEO
    Planned sale
    $133K 25,000 shares at $5.31 2.1% of stake
    Traded Dec 29, 2025 Filed Dec 29, 2025
  10. Mark Alvino Director
    Sale
    $71K 15,000 shares at $4.74 19% of stake
    Traded Nov 13, 2025 Filed Nov 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 29 sales to cover taxes, 13 stock grants, 1 gift, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01,9.01
8-K 1.01,2.01,3.02,7.01,9.01
SCHEDULE 13D —
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
424B3
8-K 5.02
8-K 5.07
8-K 7.01,9.01
8-K 8.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf